STOK
Stoke Therapeutics, Inc.
$32.29
+2.83%
2026-08-21
About Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in Phase 1 clinical trials for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase 3 clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Key Fundamentals
P/E Ratio
51.34
Forward P/E
-8.95
EPS (TTM)
$-3.39
ROE
-61.1%
Revenue Growth (YoY)
-32.5%
Profit Margin
0.0%
Debt/Equity
0.78
Price/Book
5.65
Beta
1.23
Market Cap
$2.02B
Avg Volume (10D)
1.0M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$33.72
60D Low
$27.24
Avg Volume
828K
Latest Close
$32.29
Get breakout alerts for STOK
Sign up for Breakout Scanner to receive daily notifications when STOK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Stoke Therapeutics, Inc. (STOK) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors STOK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. STOK operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.